CALCIMEDICA INC (CALC) Stock Income Statement
USA - NASDAQ:CALC - US38942Q2021 - Common Stock
3.04 USD
-0.02 (-0.65%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 24.93M | 24.20M | 38.08M | 33.22M | 35.95M | |||
| Research and Development | 15.76M | 14.48M | 15.86M | 14.11M | 18.90M | |||
| Selling, General, and Administrative Expenses | 9.18M | 9.73M | 22.22M | 19.10M | 17.04M | |||
| Operating Income | -24.93M | -24.20M | -38.08M | -33.22M | -35.95M | |||
| Interest Income/Expense | 5.15M | 9.49M | 1.91M | 580.00K | 130.00K | |||
| Other Income/Expense | 909.00K | 1.01M | 1.81M | null | 0 | |||
| Non Recurring Items | null | null | null | -2.96M | null | |||
| Income Before Taxes | -18.87M | -13.70M | -34.36M | -35.61M | -35.82M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -18.87M | -13.70M | -34.36M | -35.61M | -35.82M | |||
| EBITDA | -24.88M | -24.15M | -38.02M | -32.88M | -35.43M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.5453999999999999 | -1.2182 | -7.6583 | -23.27 | -23.72 | |||
| Non GAAP EPS | -1.6 | -1.23 | -25.59 | null | -7.0200000000000005 | |||
| Statistics | ||||||||
All data in USD